Where Will Rigetti Computing Stock Be in 3 Years?

Rigetti’s CEO said “commercial revenue remains early,” with Q2 sales up 185% but only to just over $5.1M, highlighting the long runway to meaningful commercial scale. The company is progressing via a hybrid quantum-classical collaboration with Hewlett Packard and the Pittsburgh Supercomputing Center, plus a U.S. Department of Commerce letter of intent for up to $100M over three years. While shares have risen ~718% over three years, the article argues AI momentum may continue diverting investor attention from quantum, making it unlikely to replicate prior returns.

Analysis

The key market mechanism here is not near-term revenue, it’s duration mismatch: quantum names trade on optionality while AI leaders are monetizing today, so capital will keep migrating toward self-funding growth unless quantum converts technical milestones into repeatable bookings. That makes pure-play quantum stocks vulnerable to multiple compression even if the underlying science improves, because every quarter without scalable commercial revenue raises the implied discount rate on the story.

Relative winners are the picks-and-shovels layers that can monetize hybrid workflows first. HPE has the cleanest adjacency because enterprise and research buyers can spend on HPC, orchestration, and integration without waiting for fault-tolerant quantum; that’s a small revenue line today, but it can become a low-risk attach opportunity if quantum-classical pilots proliferate. NVDA is also a beneficiary of the broader “AI infrastructure first” trade: even if quantum eventually improves model training or optimization, the cash flows accrue to the incumbent compute stack long before a quantum-native budget exists.

The contrarian miss is that the best quantum exposure may be through the enablers, not the pure-play equity. RGTI can still work as a sentiment-driven squeeze vehicle, but the three-year path is littered with binary catalysts: conversion of government funding, proof that collaborations turn into paid deployments, and whether management can show a meaningful step-up in backlog rather than press-release momentum. If those do not materialize within 1-3 quarters, the stock likely re-rates lower despite the long-dated upside case.

From a risk perspective, the main falsifier is a credible commercialization inflection: signed funding, repeat customers, or guided revenue growth that starts to look non-linear rather than experimental. Absent that, any rally is likely to lag AI-linked names over the next 6-18 months as portfolio flows continue to reward cash generation and tangible capex beneficiaries.

Key Decisions for Investors

• Favor long NVDA / short RGTI as a 1-3 month relative-value expression of capital rotation from speculative optionality to monetized AI infrastructure; risk/reward improves if RGTI rallies on sentiment without new revenue evidence.
• Avoid chasing RGTI on strength; if holding a speculative sleeve, size it as a small optionality position only and use any post-hype pop to trim, since the stock’s multiple is still more sensitive to narrative decay than to current sales.
• Modestly overweight HPE versus pure-play quantum peers on a 6-12 month horizon: it can capture hybrid quantum-classical spend with much lower execution risk, though the thesis is incremental rather than transformative.
• Set an alert for any confirmed conversion of government or strategic collaboration dollars into booked revenue; that is the first real catalyst that can extend the tape beyond another momentum trade.
• If RGTI’s next earnings show no acceleration in bookings/backlog despite the cash balance, consider a tactical short against QUBT or a broader speculative-tech basket; the trade is about relative disappointment, not bankruptcy risk.